Catheter complications associated with intraperitoneal chemotherapy.
Intraperitoneal administration of chemotherapy in ovarian carcinoma is currently under investigation. Numerous recent publications have described clinical studies employing a variety of chemotherapeutic drugs. Little information exists regarding the delivery systems employed or the complications encountered. This study reviews our experience with "single-use" and "long-term" catheters. Thirty-three catheters were placed in 28 patients. Of these catheters, 12 were long-term Tenckhoff catheters and 21 were temporary single-use catheters. Both types of catheters had complications associated with their usage. However, there was a dramatic difference in the number and severity of complications when the two groups were compared. Sixty-seven percent of the Tenckhoff catheters were associated with complications. Nineteen percent of the patients with single-use catheters experienced complications. This 19%, however, represented only 3.8% of the total number of single-use catheter insertions. In our hands, the temporary percutaneous approach has been a safe one, which is technically easy to perform with minimal complications.
C D
CD
Runowicz
P R
PR
Dottino
M K
MK
Shafir
M A
MA
Mark
C J
CJ
Cohen
D002404:Catheterization / Q000009:adverse effects*; D002945:Cisplatin / Q000008:administration & dosage*; D005260:Female; D006406:Hematoma / Q000209:etiology; D006801:Humans; D010051:Ovarian Neoplasms / Q000188:drug therapy*
D002945:Cisplatin